» Journals » Curr Gene Ther

Current Gene Therapy

Current Gene Therapy is a peer-reviewed journal that focuses on the latest advancements in gene therapy research and its applications. It provides a platform for scientists, clinicians, and researchers to share their findings, methodologies, and insights in the field. The journal covers a wide range of topics, including gene delivery systems, gene editing techniques, therapeutic applications, and clinical trials, making it an essential resource for those interested in the rapidly evolving field of gene therapy.

Details
Abbr. Curr Gene Ther
Start 2001
End Continuing
Frequency Bimonthly
p-ISSN 1566-5232
e-ISSN 1875-5631
Language English
Specialties Pharmacology
Genetics
Metrics
h-index / Ranks: 4372 80
SJR / Ranks: 6612 674
CiteScore / Ranks: 2975 6.90
JIF / Ranks: 2654 3.6
Recent Articles
1.
Manchanda D, Kumar S, Makhija M
Curr Gene Ther . 2025 Mar; PMID: 40070071
The advent of CRISPR/Cas gene-editing technology has revolutionized molecular biology, offering unprecedented precision and potential in treating genetic disorders, cancers, and other complex diseases. However, for CRISPR/Cas to be truly...
2.
Veldsman W, Zhang Q, Zhao Q, Zhang L, Yuanjie Z
Curr Gene Ther . 2025 Feb; PMID: 40012382
Introduction: Antimicrobial peptides (AMPs), unlike antibiotics, are encoded in genomes. AMPs are exported from the cell after expression and translation. In the case of bacteria, the exported peptides target other...
3.
Ahmed Mohamed Moustafa H, Sohaib A, Saleem I, Ullah A
Curr Gene Ther . 2025 Feb; PMID: 39976089
Background: Individualization of the therapeutic plan for cancer patients is the essence of modern clinical practice. Standard cancer diagnostic and prognostic factors are invasive, and their value for the stratification...
4.
Sen A, Singh V, Dwivedi S, Agrawal R, Bansal A, Shekhar S, et al.
Curr Gene Ther . 2025 Feb; PMID: 39976035
Gene therapy and genome editing have emerged as transformative approaches in the management of a diverse range of genetic and acquired diseases. This evaluation offers a thorough examination of the...
5.
M S, Kadiri S
Curr Gene Ther . 2025 Feb; PMID: 39945257
This article provides a detailed look at Parkinson's disease (PD), a neurodegenerative ailment mostly known for movement difficulties such tremor, stiffness, and bradykinesia, which affects approximately 1% of persons over...
6.
Sharma R, Kumar S, Ghosh R, Komal K, Kumar M
Curr Gene Ther . 2025 Feb; PMID: 39936422
Pancreatic cancer remains one of the most aggressive and lethal malignancies, with a dismal prognosis despite advancements in conventional treatment modalities. Gene therapy has emerged as a promising approach to...
7.
Jin H, Wan M, Pan S, Wang Z, Wang W, Zhang J, et al.
Curr Gene Ther . 2025 Feb; PMID: 39936421
Introduction: The absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) is a hallmark of triple-negative breast cancer (TNBC), which results in...
8.
Roy S, Barman A, Sarkar K, Richard S, Lacmane B
Curr Gene Ther . 2025 Feb; PMID: 39934995
"Huntington's disease" (HD) is an autosomal dominant hereditary neurodegenerative disease characterized by defects in efferent striatal neurons, cortical neurons, and the basal ganglia. The pathogenesis of HD is still unclear,...
9.
Jan S, Debnath A, Singh R, Tyagi P, Singh S, Singh A
Curr Gene Ther . 2025 Feb; PMID: 39917924
The field of drug discovery has long been challenged by the existence of "undruggable" proteins - targets that have resisted traditional small molecule approaches due to their structural or functional...
10.
Roy A, Pokale R, Mukharya A, Nikam A, Dua K, Rao B, et al.
Curr Gene Ther . 2025 Jan; PMID: 39871553
The evolution of genetic exploration tools, from laborious methods like radiationinduced mutations to the transformative CRISPR-Cas9 system, has fundamentally reshaped genetic research and gene editing capabilities. This journey, initiated by...